Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies

Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies

US Patent 8206711 · Granted Jun 26, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2019
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2019
Combination therapies for B-cell lymphomas comprising administration of anti-CD22018
Treatment of pemphigus2018
Treatment of pemphigus2018
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2016
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2016
Combination therapies for B-cell lymphomas comprising administration of anti-CD22016
Treatment of cancer using hypoxia activated prodrugs2015
Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs2014
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2014
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2014